Genmab | Capital Ordinário



Ordinary Share Capital Alterar Data
Agios Pharmaceuticals USD 74K 1000 2025-03
Almirall EUR 25.62M 0 2024-12
Amarin USD 308.15M 2.85M 2025-03
Amgen USD 33.58B 45M 2025-03
argenx SE 60.76M 964.68K 2024-12
AstraZeneca USD 388M 0 2025-03
Bayer EUR 2.52B 0 2025-03
BioMarin Pharmaceutical USD 192K 1000 2025-03
Demant DKK 44M 1000K 2024-12
Exelixis USD 275K 7K 2025-04
Fresenius Medical Care EUR 293.41M 0 2025-03
Galapagos EUR 293.94M 0 2025-03
Genmab DKK 10M 56M 2025-03
GlaxoSmithKline GBP 1.35B 1000K 2025-03
GN Store Nord DKK 604M 0 2025-03
GRIFOLS EUR 119.6M 0 2025-03
Hikma Pharmaceutical USD 40M 0 2024-12
Insmed USD 1.82M 25K 2025-03
Lonza CHF 72M 0 2024-12
Merck EUR 565M 397M 2025-03
Novartis USD 793M 0 2024-12
Regeneron Pharmaceuticals USD 0 102K 2025-03
Roche Holding CHF 107M 0 2024-06
Sanofi 1.25B 52.53M 2025-03
UCB EUR 584M 0 2024-12


Genmab Capital Ordinário - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Jul 2025.